Stackhouse was diagnosed with narcolepsy during his first year at Georgia, where he started 42 games and won two national ...
Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the publication of six manuscripts covering clinical ...
Despite decades of research, scientists admit that they still have a lot to learn about sleep. In general, sleep can be ...
Avadel Pharmaceuticals plc has published six manuscripts in a CNS Drugs supplement titled "A New Dawn in the Management of Narcolepsy," focusing on clinical management strategies, shared decision ...
American Century Companies Inc. raised its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 55.7% in the fourth quarter, Holdings Channel.com reports. The firm owned ...
Clinical Trials Arena on MSN5d
Axsome’s Sunosi succeeds in Phase III ADHD trialThe randomised trial saw more than half of patients dosed with Sunosi achieving clinical response to the therapy used to ...
MyChesCo on MSN11h
Harmony Biosciences Names Adam Zaeske as Chief Commercial OfficerHarmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced the appointment of Adam Zaeske as its new Executive Vice ...
Taking a gamble by purchasing the rights to an underperforming narcolepsy drug may soon begin paying dividends for Axsome ...
WACC (Weighted Average Cost of Capital): 11.05%, coming from 11.5% cost of equity (about 11% I use for a no-moat stock, but I ...
Avadel Pharmaceuticals (AVDL) announced the publication of six manuscripts covering clinical management, shared decision-making and goal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback